嶸泰股份(605133.SH):公開發行可轉債募投項目結項並將節餘募集資金永久補充流動資金
格隆匯7月3日丨嶸泰股份(605133.SH)公佈,公司於2024年7月3日召開第二屆董事會第二十六次會議、第二屆監事會第二十三次會議,審議通過了《關於公開發行可轉債募投項目結項並將節餘募集資金永久補充流動資金的議案》,同意公司將公開發行可轉債募投項目結項,並將募投項目專户截至2024年6月30日的餘額(含理財收益及利息收入)2,943.25萬元,以及後續募集資金專户註銷前產生的利息收入與手續費差額所形成的節餘款(實際金額以資金轉出當日專户餘額為準)永久性補充流動資金,用於公司日常生產經營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.